Event Brief
Eli Lilly to buy AtaiBeckley for $2.8 billion
Filed: Jul 16, 2026 at 9:00 AM ET
Summary: Eli Lilly agreed to acquire AtaiBeckley for $2.8 billion to access experimental DMT and MDMA-based treatments.
WHO: Eli Lilly
WHAT: Agreed to acquire AtaiBeckley for $2.8 billion
WHEN: Jul 16, 2026 at 6:48 AM ET
WHERE: Location not specified
WHY: To gain access to AtaiBeckley’s experimental drugs based on DMT and MDMA.
ℹ️ This event is analyzed using pattern arcs, velocity indicators, and source analysis in our MI Console.
Know more. Read less.
The BriefBrief follows the story, so you don't have to read every article. See what happened, how it changed, and where it came from, all in one place.
Same format. Every time.
See how stories unfold →